Swiss National Bank Sells 20,900 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Swiss National Bank reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 5.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 357,900 shares of the company's stock after selling 20,900 shares during the period. Swiss National Bank owned 0.29% of Henry Schein worth $24,767,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Principal Financial Group Inc. grew its stake in shares of Henry Schein by 2.1% in the third quarter. Principal Financial Group Inc. now owns 145,835 shares of the company's stock valued at $10,631,000 after acquiring an additional 3,037 shares in the last quarter. Huntington National Bank raised its stake in Henry Schein by 16.8% during the third quarter. Huntington National Bank now owns 1,515 shares of the company's stock worth $110,000 after acquiring an additional 218 shares in the last quarter. CIBC Asset Management Inc lifted its holdings in shares of Henry Schein by 7.0% in the third quarter. CIBC Asset Management Inc now owns 17,680 shares of the company's stock worth $1,289,000 after acquiring an additional 1,162 shares during the last quarter. Natixis Advisors LLC boosted its stake in shares of Henry Schein by 18.8% in the 3rd quarter. Natixis Advisors LLC now owns 81,877 shares of the company's stock valued at $5,969,000 after purchasing an additional 12,930 shares in the last quarter. Finally, Thrivent Financial for Lutherans grew its holdings in shares of Henry Schein by 1,848.9% during the 3rd quarter. Thrivent Financial for Lutherans now owns 105,415 shares of the company's stock valued at $7,685,000 after purchasing an additional 100,006 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Remove Ads

Henry Schein Trading Down 1.5 %

HSIC stock traded down $1.06 during midday trading on Friday, hitting $69.39. The stock had a trading volume of 1,473,143 shares, compared to its average volume of 1,509,153. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a market cap of $8.62 billion, a P/E ratio of 28.56, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The business has a fifty day moving average price of $74.83 and a two-hundred day moving average price of $72.61. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same period in the prior year, the firm earned $0.66 earnings per share. The firm's revenue for the quarter was up 5.8% compared to the same quarter last year. On average, sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HSIC. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and raised their target price for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Mizuho began coverage on Henry Schein in a report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price objective on the stock. Jefferies Financial Group upped their target price on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. UBS Group cut their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Finally, Wells Fargo & Company started coverage on Henry Schein in a research note on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective for the company. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.